Compounds > 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline
Page last updated: 2024-10-29

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Systemic Inflammatory Response Syndrome

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Systemic Inflammatory Response Syndrome in 1 studies

WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration

Systemic Inflammatory Response Syndrome: A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uckun, FM1
Tibbles, H1
Ozer, Z1
Qazi, S1
Vassilev, A1

Other Studies

1 other study available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Systemic Inflammatory Response Syndrome

ArticleYear
Anti-inflammatory activity profile of JANEX-1 in preclinical animal models.
    Bioorganic & medicinal chemistry, 2008, Feb-01, Volume: 16, Issue:3

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Cell Line; Disease Models, Animal; Drug Evaluation

2008